11762 related articles for article (PubMed ID: 10338155)
1. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines.
Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
Oncol Res; 1998; 10(10):523-31. PubMed ID: 10338155
[TBL] [Abstract][Full Text] [Related]
2. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
Aduma P; Connelly MC; Srinivas RV; Fridland A
Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
[TBL] [Abstract][Full Text] [Related]
3. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
Andrei G; De Clercq E; Snoeck R
Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells.
Andrei G; Snoeck R; Schols D; De Clercq E
Oncol Res; 2000; 12(9-10):397-408. PubMed ID: 11697818
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting effects of cidofovir (HPMPC) on the growth of the human cervical carcinoma (SiHa) xenografts in athymic nude mice.
Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
Oncol Res; 1998; 10(10):533-9. PubMed ID: 10338156
[TBL] [Abstract][Full Text] [Related]
6. Activities of acyclic nucleoside phosphonates against Orf virus in human and ovine cell monolayers and organotypic ovine raft cultures.
Dal Pozzo F; Andrei G; Holy A; Van Den Oord J; Scagliarini A; De Clercq E; Snoeck R
Antimicrob Agents Chemother; 2005 Dec; 49(12):4843-52. PubMed ID: 16304144
[TBL] [Abstract][Full Text] [Related]
7. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
[TBL] [Abstract][Full Text] [Related]
8. Influence of intravitreal injections of HPMPC and related nucleoside analogues on intraocular pressure in guinea pig eyes.
Banker AS; De Clercq E; Taskintuna I; Keefe KS; Bergeron-Lynn G; Freeman WR
Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1233-42. PubMed ID: 9620084
[TBL] [Abstract][Full Text] [Related]
9. Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
Snoeck R; Andrei G; De Clercq E
Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):574-9. PubMed ID: 8874075
[TBL] [Abstract][Full Text] [Related]
10. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
Neyts J; De Clercq E
Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.
Reymen D; Naesens L; Balzarini J; Holý A; Dvoráková H; De Clercq E
Antiviral Res; 1995 Dec; 28(4):343-57. PubMed ID: 8669893
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
De Clercq E
Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
Smee DF; Barnett BB; Sidwell RW; Reist EJ; Holy A
Antiviral Res; 1995 Jan; 26(1):1-9. PubMed ID: 7741517
[TBL] [Abstract][Full Text] [Related]
14. Activities of various compounds against murine and primate polyomaviruses.
Andrei G; Snoeck R; Vandeputte M; De Clercq E
Antimicrob Agents Chemother; 1997 Mar; 41(3):587-93. PubMed ID: 9055998
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of novel acyclic nucleoside phosphonates against human and animal gammaherpesviruses revealed an altered metabolism of cyclic prodrugs upon Epstein-Barr virus reactivation in P3HR-1 cells.
Coen N; Duraffour S; Naesens L; Krecmerová M; Van den Oord J; Snoeck R; Andrei G
J Virol; 2013 Nov; 87(22):12422-32. PubMed ID: 24027315
[TBL] [Abstract][Full Text] [Related]
16. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948
[TBL] [Abstract][Full Text] [Related]
17. Antitumor potential of acyclic nucleoside phosphonates.
De Clercq E; Andrei G; Balzarini J; Hatse S; Liekens S; Naesens L; Neyts J; Snoeck R
Nucleosides Nucleotides; 1999; 18(4-5):759-71. PubMed ID: 10432678
[TBL] [Abstract][Full Text] [Related]
18. Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.
Abdulkarim B; Sabri S; Deutsch E; Chagraoui H; Maggiorella L; Thierry J; Eschwege F; Vainchenker W; Chouaïb S; Bourhis J
Oncogene; 2002 Apr; 21(15):2334-46. PubMed ID: 11948417
[TBL] [Abstract][Full Text] [Related]
19. The combination of the antiviral agent cidofovir and anti-EGFR antibody cetuximab exerts an antiproliferative effect on HPV-positive cervical cancer cell lines' in-vitro and in-vivo xenografts.
Deberne M; Levy A; Mondini M; Dessen P; Vivet S; Supiramaniam A; Vozenin MC; Deutsch E
Anticancer Drugs; 2013 Jul; 24(6):599-608. PubMed ID: 23698251
[TBL] [Abstract][Full Text] [Related]
20. Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia.
Andrei G; Topalis D; De Schutter T; Snoeck R
Antiviral Res; 2015 Feb; 114():21-46. PubMed ID: 25446403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
